Compare Supplements

There is no established or legitimate human dose. Unifiram (DM-232) is a preclinical-only grey-market 'research chemical' with NO human clinical trials, no human pharmacokinetic data, no approval and no pharmacovigilance — this library does NOT provide a dosing protocol. Vendors and forums quote figures in the single-to-low-tens of milligrams orally, but these are pure extrapolation, not validated for a product of unknown identity and purity taken without supervision or monitoring. The only quantitative figure in the literature is an animal one — DM-232 was active at about 0.001 mg/kg subcutaneously in the mouse passive-avoidance test (Manetti 2000) — which is a rodent research dose by a non-oral route, NOT a human recommendation and not convertible into one.

Morning

No human form is endorsed — unifiram is a preclinical-only 'research chemical' with no approved or supplement form

• Any human use — unifiram (DM-232) is a preclinical-only grey-market 'research chemical' with NO human trials, no approval, and product of unverified identity, purity and dose; it is NOT a dietary supplement and NOT an approved medicine
• Anyone seeking it for memory, focus or 'nootropic' enhancement — there is no human evidence of benefit for unifiram and a presumed excitatory/stimulant harm profile
• Anyone with a seizure disorder or lowered seizure threshold — unifiram potentiates AMPA-mediated glutamatergic excitation, which carries theoretical seizure/excitotoxicity risk

• Other stimulants / nootropics / cholinergics
• Glutamatergic / AMPA-modulating agents
• Drugs that lower the seizure threshold